Moreover, treatment of ovarian cancer cell lines with TSA alone had no effect on the expression level of CTGF, whereas in A549 and Calu-1 cells it significantly induced CTGF mRNA and protein content, suggesting that down-regulation of this gene in NSCLC cells and in ovarian cancer cells has distinct molecular basis. This evidence concerns the gene CCN2 and ovarian carcinoma.